Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes
Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes have?
Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes has 185 citations in the OpenAlex counts ScholarIQ stores.
When was Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes published?
Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes has 2015 year in the ScholarIQ index.
What is the open-access status of Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes?
Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes?
The DOI for Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes is on the source record.
What is the PMID of Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes?
The PMID for Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes is on the source record.
What is the OpenAlex record for Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes?
The OpenAlex for Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes is on the source record.